nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—Propofol—epilepsy syndrome	0.14	0.218	CbGbCtD
Thiabendazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.133	0.208	CbGbCtD
Thiabendazole—CYP1A2—Carbamazepine—epilepsy syndrome	0.0746	0.116	CbGbCtD
Thiabendazole—CYP1A2—Primidone—epilepsy syndrome	0.0696	0.109	CbGbCtD
Thiabendazole—CYP1A2—Propofol—epilepsy syndrome	0.0624	0.0974	CbGbCtD
Thiabendazole—CYP1A2—Phenobarbital—epilepsy syndrome	0.0596	0.0931	CbGbCtD
Thiabendazole—CYP1A2—Diazepam—epilepsy syndrome	0.0565	0.0883	CbGbCtD
Thiabendazole—CYP1A2—Valproic Acid—epilepsy syndrome	0.0446	0.0696	CbGbCtD
Thiabendazole—Lansoprazole—ABCG2—epilepsy syndrome	0.00166	0.359	CrCbGaD
Thiabendazole—Lansoprazole—CYP2C19—epilepsy syndrome	0.00131	0.282	CrCbGaD
Thiabendazole—Lansoprazole—CYP2D6—epilepsy syndrome	0.00097	0.209	CrCbGaD
Thiabendazole—Lansoprazole—ABCB1—epilepsy syndrome	0.000692	0.149	CrCbGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—MAP2—epilepsy syndrome	0.00036	0.0151	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—MAPK10—epilepsy syndrome	0.000357	0.015	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.000325	0.0136	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000317	0.0133	CbGpPWpGaD
Thiabendazole—Pruritus—Levetiracetam—epilepsy syndrome	0.000316	0.000955	CcSEcCtD
Thiabendazole—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000315	0.000953	CcSEcCtD
Thiabendazole—Chills—Pregabalin—epilepsy syndrome	0.000314	0.000949	CcSEcCtD
Thiabendazole—Headache—Acetazolamide—epilepsy syndrome	0.000312	0.000942	CcSEcCtD
Thiabendazole—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000311	0.000941	CcSEcCtD
Thiabendazole—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000311	0.000941	CcSEcCtD
Thiabendazole—Abdominal pain—Zonisamide—epilepsy syndrome	0.00031	0.000936	CcSEcCtD
Thiabendazole—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00031	0.000936	CcSEcCtD
Thiabendazole—Asthenia—Fosphenytoin—epilepsy syndrome	0.000309	0.000935	CcSEcCtD
Thiabendazole—Visual impairment—Gabapentin—epilepsy syndrome	0.000309	0.000935	CcSEcCtD
Thiabendazole—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000309	0.000934	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000309	0.000933	CcSEcCtD
Thiabendazole—Fatigue—Carbamazepine—epilepsy syndrome	0.000309	0.000933	CcSEcCtD
Thiabendazole—Angioedema—Valproic Acid—epilepsy syndrome	0.000308	0.000931	CcSEcCtD
Thiabendazole—Somnolence—Lamotrigine—epilepsy syndrome	0.000308	0.00093	CcSEcCtD
Thiabendazole—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000308	0.000929	CcSEcCtD
Thiabendazole—Dizziness—Propofol—epilepsy syndrome	0.000306	0.000924	CcSEcCtD
Thiabendazole—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000306	0.000924	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000305	0.000922	CcSEcCtD
Thiabendazole—Pruritus—Fosphenytoin—epilepsy syndrome	0.000305	0.000922	CcSEcCtD
Thiabendazole—Hypersensitivity—Diazepam—epilepsy syndrome	0.000305	0.000921	CcSEcCtD
Thiabendazole—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000305	0.000921	CcSEcCtD
Thiabendazole—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000304	0.00092	CcSEcCtD
Thiabendazole—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000304	0.000917	CcSEcCtD
Thiabendazole—Leukopenia—Valproic Acid—epilepsy syndrome	0.000302	0.000912	CcSEcCtD
Thiabendazole—Asthenia—Vigabatrin—epilepsy syndrome	0.000302	0.000911	CcSEcCtD
Thiabendazole—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000301	0.000909	CcSEcCtD
Thiabendazole—Tinnitus—Gabapentin—epilepsy syndrome	0.000299	0.000904	CcSEcCtD
Thiabendazole—Dizziness—Midazolam—epilepsy syndrome	0.000299	0.000904	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000299	0.0125	CbGpPWpGaD
Thiabendazole—Abdominal pain—Clonazepam—epilepsy syndrome	0.000299	0.000902	CcSEcCtD
Thiabendazole—Fatigue—Lamotrigine—epilepsy syndrome	0.000298	0.000902	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000298	0.000901	CcSEcCtD
Thiabendazole—Pruritus—Vigabatrin—epilepsy syndrome	0.000297	0.000898	CcSEcCtD
Thiabendazole—Asthenia—Diazepam—epilepsy syndrome	0.000297	0.000897	CcSEcCtD
Thiabendazole—Nausea—Acetazolamide—epilepsy syndrome	0.000296	0.000893	CcSEcCtD
Thiabendazole—Dizziness—Levetiracetam—epilepsy syndrome	0.000295	0.000893	CcSEcCtD
Thiabendazole—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000295	0.000892	CcSEcCtD
Thiabendazole—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000295	0.000892	CcSEcCtD
Thiabendazole—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000295	0.000891	CcSEcCtD
Thiabendazole—Vomiting—Propofol—epilepsy syndrome	0.000294	0.000888	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000293	0.000885	CcSEcCtD
Thiabendazole—Pruritus—Diazepam—epilepsy syndrome	0.000293	0.000884	CcSEcCtD
Thiabendazole—Rash—Propofol—epilepsy syndrome	0.000292	0.000881	CcSEcCtD
Thiabendazole—Dermatitis—Propofol—epilepsy syndrome	0.000291	0.00088	CcSEcCtD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	0.000291	0.0122	CbGpPWpGaD
Thiabendazole—Headache—Propofol—epilepsy syndrome	0.00029	0.000875	CcSEcCtD
Thiabendazole—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000289	0.000873	CcSEcCtD
Thiabendazole—Chills—Gabapentin—epilepsy syndrome	0.000288	0.00087	CcSEcCtD
Thiabendazole—Vomiting—Midazolam—epilepsy syndrome	0.000288	0.000869	CcSEcCtD
Thiabendazole—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000288	0.000869	CcSEcCtD
Thiabendazole—Asthenia—Felbamate—epilepsy syndrome	0.000287	0.000868	CcSEcCtD
Thiabendazole—Vision blurred—Pregabalin—epilepsy syndrome	0.000287	0.000868	CcSEcCtD
Thiabendazole—Haematuria—Topiramate—epilepsy syndrome	0.000287	0.000867	CcSEcCtD
Thiabendazole—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000285	0.000862	CcSEcCtD
Thiabendazole—Rash—Midazolam—epilepsy syndrome	0.000285	0.000862	CcSEcCtD
Thiabendazole—Dizziness—Fosphenytoin—epilepsy syndrome	0.000285	0.000861	CcSEcCtD
Thiabendazole—Dermatitis—Midazolam—epilepsy syndrome	0.000285	0.000861	CcSEcCtD
Thiabendazole—Vomiting—Levetiracetam—epilepsy syndrome	0.000284	0.000858	CcSEcCtD
Thiabendazole—Headache—Midazolam—epilepsy syndrome	0.000283	0.000856	CcSEcCtD
Thiabendazole—Pruritus—Felbamate—epilepsy syndrome	0.000283	0.000856	CcSEcCtD
Thiabendazole—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000283	0.000856	CcSEcCtD
Thiabendazole—Diarrhoea—Diazepam—epilepsy syndrome	0.000283	0.000855	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000283	0.000855	CcSEcCtD
Thiabendazole—Rash—Levetiracetam—epilepsy syndrome	0.000282	0.000851	CcSEcCtD
Thiabendazole—Dermatitis—Levetiracetam—epilepsy syndrome	0.000281	0.00085	CcSEcCtD
Thiabendazole—Asthenia—Zonisamide—epilepsy syndrome	0.000281	0.00085	CcSEcCtD
Thiabendazole—Headache—Levetiracetam—epilepsy syndrome	0.00028	0.000846	CcSEcCtD
Thiabendazole—CYP1A2—Xenobiotics—CYP2C19—epilepsy syndrome	0.000279	0.0117	CbGpPWpGaD
Thiabendazole—Angioedema—Pregabalin—epilepsy syndrome	0.000278	0.000841	CcSEcCtD
Thiabendazole—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000278	0.000841	CcSEcCtD
Thiabendazole—Dizziness—Vigabatrin—epilepsy syndrome	0.000278	0.00084	CcSEcCtD
Thiabendazole—Confusional state—Valproic Acid—epilepsy syndrome	0.000277	0.000838	CcSEcCtD
Thiabendazole—Pruritus—Zonisamide—epilepsy syndrome	0.000277	0.000838	CcSEcCtD
Thiabendazole—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000276	0.000835	CcSEcCtD
Thiabendazole—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000275	0.000831	CcSEcCtD
Thiabendazole—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000275	0.000831	CcSEcCtD
Thiabendazole—Nausea—Propofol—epilepsy syndrome	0.000275	0.00083	CcSEcCtD
Thiabendazole—Vomiting—Fosphenytoin—epilepsy syndrome	0.000274	0.000828	CcSEcCtD
Thiabendazole—Diarrhoea—Felbamate—epilepsy syndrome	0.000274	0.000828	CcSEcCtD
Thiabendazole—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000274	0.000827	CcSEcCtD
Thiabendazole—Dizziness—Diazepam—epilepsy syndrome	0.000274	0.000827	CcSEcCtD
Thiabendazole—Leukopenia—Pregabalin—epilepsy syndrome	0.000273	0.000824	CcSEcCtD
Thiabendazole—Rash—Fosphenytoin—epilepsy syndrome	0.000272	0.000821	CcSEcCtD
Thiabendazole—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000272	0.000821	CcSEcCtD
Thiabendazole—Asthenia—Clonazepam—epilepsy syndrome	0.000271	0.000819	CcSEcCtD
Thiabendazole—Headache—Fosphenytoin—epilepsy syndrome	0.00027	0.000816	CcSEcCtD
Thiabendazole—Asthenia—Phenytoin—epilepsy syndrome	0.000269	0.000813	CcSEcCtD
Thiabendazole—Nausea—Midazolam—epilepsy syndrome	0.000269	0.000812	CcSEcCtD
Thiabendazole—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000269	0.000812	CcSEcCtD
Thiabendazole—Diarrhoea—Zonisamide—epilepsy syndrome	0.000268	0.00081	CcSEcCtD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000268	0.0112	CbGpPWpGaD
Thiabendazole—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000268	0.000809	CcSEcCtD
Thiabendazole—Pruritus—Clonazepam—epilepsy syndrome	0.000267	0.000808	CcSEcCtD
Thiabendazole—Vomiting—Vigabatrin—epilepsy syndrome	0.000267	0.000807	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.000266	0.0111	CbGpPWpGaD
Thiabendazole—Pruritus—Phenytoin—epilepsy syndrome	0.000266	0.000802	CcSEcCtD
Thiabendazole—Nausea—Levetiracetam—epilepsy syndrome	0.000265	0.000802	CcSEcCtD
Thiabendazole—Rash—Vigabatrin—epilepsy syndrome	0.000265	0.000801	CcSEcCtD
Thiabendazole—Dizziness—Felbamate—epilepsy syndrome	0.000265	0.0008	CcSEcCtD
Thiabendazole—Dermatitis—Vigabatrin—epilepsy syndrome	0.000265	0.0008	CcSEcCtD
Thiabendazole—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000264	0.000798	CcSEcCtD
Thiabendazole—Convulsion—Pregabalin—epilepsy syndrome	0.000264	0.000798	CcSEcCtD
Thiabendazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000264	0.000797	CcSEcCtD
Thiabendazole—Vision blurred—Gabapentin—epilepsy syndrome	0.000263	0.000796	CcSEcCtD
Thiabendazole—Headache—Vigabatrin—epilepsy syndrome	0.000263	0.000795	CcSEcCtD
Thiabendazole—Vomiting—Diazepam—epilepsy syndrome	0.000263	0.000795	CcSEcCtD
Thiabendazole—Anorexia—Valproic Acid—epilepsy syndrome	0.000262	0.000792	CcSEcCtD
Thiabendazole—Rash—Diazepam—epilepsy syndrome	0.000261	0.000788	CcSEcCtD
Thiabendazole—Dermatitis—Diazepam—epilepsy syndrome	0.000261	0.000787	CcSEcCtD
Thiabendazole—Visual impairment—Topiramate—epilepsy syndrome	0.00026	0.000786	CcSEcCtD
Thiabendazole—Dizziness—Zonisamide—epilepsy syndrome	0.000259	0.000783	CcSEcCtD
Thiabendazole—Headache—Diazepam—epilepsy syndrome	0.000259	0.000783	CcSEcCtD
Thiabendazole—Diarrhoea—Clonazepam—epilepsy syndrome	0.000259	0.000781	CcSEcCtD
Thiabendazole—Hypotension—Valproic Acid—epilepsy syndrome	0.000257	0.000777	CcSEcCtD
Thiabendazole—Asthenia—Carbamazepine—epilepsy syndrome	0.000257	0.000776	CcSEcCtD
Thiabendazole—Diarrhoea—Phenytoin—epilepsy syndrome	0.000257	0.000776	CcSEcCtD
Thiabendazole—Nausea—Fosphenytoin—epilepsy syndrome	0.000256	0.000774	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RET—epilepsy syndrome	0.000256	0.0107	CbGpPWpGaD
Thiabendazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000255	0.000772	CcSEcCtD
Thiabendazole—Erythema multiforme—Topiramate—epilepsy syndrome	0.000255	0.000771	CcSEcCtD
Thiabendazole—Angioedema—Gabapentin—epilepsy syndrome	0.000255	0.000771	CcSEcCtD
Thiabendazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000255	0.000771	CcSEcCtD
Thiabendazole—Vomiting—Felbamate—epilepsy syndrome	0.000255	0.000769	CcSEcCtD
Thiabendazole—CYP1A1—Oxidative Stress—JUNB—epilepsy syndrome	0.000254	0.0107	CbGpPWpGaD
Thiabendazole—Pruritus—Carbamazepine—epilepsy syndrome	0.000253	0.000766	CcSEcCtD
Thiabendazole—Rash—Felbamate—epilepsy syndrome	0.000253	0.000763	CcSEcCtD
Thiabendazole—Dermatitis—Felbamate—epilepsy syndrome	0.000252	0.000762	CcSEcCtD
Thiabendazole—Tinnitus—Topiramate—epilepsy syndrome	0.000252	0.000761	CcSEcCtD
Thiabendazole—Headache—Felbamate—epilepsy syndrome	0.000251	0.000758	CcSEcCtD
Thiabendazole—Confusional state—Pregabalin—epilepsy syndrome	0.000251	0.000758	CcSEcCtD
Thiabendazole—Flushing—Topiramate—epilepsy syndrome	0.000251	0.000757	CcSEcCtD
Thiabendazole—Leukopenia—Gabapentin—epilepsy syndrome	0.00025	0.000756	CcSEcCtD
Thiabendazole—CYP1A2—Xenobiotics—CYP2D6—epilepsy syndrome	0.00025	0.0105	CbGpPWpGaD
Thiabendazole—Dizziness—Clonazepam—epilepsy syndrome	0.00025	0.000755	CcSEcCtD
Thiabendazole—Nausea—Vigabatrin—epilepsy syndrome	0.00025	0.000754	CcSEcCtD
Thiabendazole—Vomiting—Zonisamide—epilepsy syndrome	0.000249	0.000753	CcSEcCtD
Thiabendazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000249	0.000751	CcSEcCtD
Thiabendazole—Asthenia—Lamotrigine—epilepsy syndrome	0.000248	0.00075	CcSEcCtD
Thiabendazole—Dizziness—Phenytoin—epilepsy syndrome	0.000248	0.00075	CcSEcCtD
Thiabendazole—Rash—Zonisamide—epilepsy syndrome	0.000247	0.000747	CcSEcCtD
Thiabendazole—Dermatitis—Zonisamide—epilepsy syndrome	0.000247	0.000746	CcSEcCtD
Thiabendazole—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000247	0.000746	CcSEcCtD
Thiabendazole—Nausea—Diazepam—epilepsy syndrome	0.000246	0.000743	CcSEcCtD
Thiabendazole—Headache—Zonisamide—epilepsy syndrome	0.000246	0.000742	CcSEcCtD
Thiabendazole—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000245	0.00074	CcSEcCtD
Thiabendazole—Pruritus—Lamotrigine—epilepsy syndrome	0.000245	0.00074	CcSEcCtD
Thiabendazole—Somnolence—Valproic Acid—epilepsy syndrome	0.000245	0.000739	CcSEcCtD
Thiabendazole—Chills—Topiramate—epilepsy syndrome	0.000242	0.000732	CcSEcCtD
Thiabendazole—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000242	0.000732	CcSEcCtD
Thiabendazole—Convulsion—Gabapentin—epilepsy syndrome	0.000242	0.000731	CcSEcCtD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.00024	0.0101	CbGpPWpGaD
Thiabendazole—Vomiting—Clonazepam—epilepsy syndrome	0.00024	0.000726	CcSEcCtD
Thiabendazole—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000239	0.000723	CcSEcCtD
Thiabendazole—Vomiting—Phenytoin—epilepsy syndrome	0.000239	0.000721	CcSEcCtD
Thiabendazole—Rash—Clonazepam—epilepsy syndrome	0.000238	0.00072	CcSEcCtD
Thiabendazole—Dermatitis—Clonazepam—epilepsy syndrome	0.000238	0.000719	CcSEcCtD
Thiabendazole—Nausea—Felbamate—epilepsy syndrome	0.000238	0.000719	CcSEcCtD
Thiabendazole—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000237	0.000717	CcSEcCtD
Thiabendazole—Fatigue—Valproic Acid—epilepsy syndrome	0.000237	0.000717	CcSEcCtD
Thiabendazole—Anorexia—Pregabalin—epilepsy syndrome	0.000237	0.000716	CcSEcCtD
Thiabendazole—Dizziness—Carbamazepine—epilepsy syndrome	0.000237	0.000716	CcSEcCtD
Thiabendazole—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000237	0.000716	CcSEcCtD
Thiabendazole—Headache—Clonazepam—epilepsy syndrome	0.000237	0.000715	CcSEcCtD
Thiabendazole—Rash—Phenytoin—epilepsy syndrome	0.000237	0.000715	CcSEcCtD
Thiabendazole—Dermatitis—Phenytoin—epilepsy syndrome	0.000236	0.000714	CcSEcCtD
Thiabendazole—Rash—Oxcarbazepine—epilepsy syndrome	0.000235	0.000711	CcSEcCtD
Thiabendazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000235	0.00071	CcSEcCtD
Thiabendazole—Headache—Phenytoin—epilepsy syndrome	0.000235	0.00071	CcSEcCtD
Thiabendazole—Headache—Oxcarbazepine—epilepsy syndrome	0.000234	0.000707	CcSEcCtD
Thiabendazole—CYP1A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000234	0.0098	CbGpPWpGaD
Thiabendazole—Nausea—Zonisamide—epilepsy syndrome	0.000233	0.000703	CcSEcCtD
Thiabendazole—Hypotension—Pregabalin—epilepsy syndrome	0.000232	0.000702	CcSEcCtD
Thiabendazole—Confusional state—Gabapentin—epilepsy syndrome	0.00023	0.000695	CcSEcCtD
Thiabendazole—Dizziness—Lamotrigine—epilepsy syndrome	0.000229	0.000692	CcSEcCtD
Thiabendazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000228	0.000689	CcSEcCtD
Thiabendazole—Vomiting—Carbamazepine—epilepsy syndrome	0.000228	0.000688	CcSEcCtD
Thiabendazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000227	0.000685	CcSEcCtD
Thiabendazole—Rash—Carbamazepine—epilepsy syndrome	0.000226	0.000682	CcSEcCtD
Thiabendazole—Dermatitis—Carbamazepine—epilepsy syndrome	0.000226	0.000682	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000225	0.00068	CcSEcCtD
Thiabendazole—Nausea—Clonazepam—epilepsy syndrome	0.000224	0.000678	CcSEcCtD
Thiabendazole—Headache—Carbamazepine—epilepsy syndrome	0.000224	0.000678	CcSEcCtD
Thiabendazole—Nausea—Phenytoin—epilepsy syndrome	0.000223	0.000673	CcSEcCtD
Thiabendazole—Nausea—Oxcarbazepine—epilepsy syndrome	0.000222	0.00067	CcSEcCtD
Thiabendazole—Vision blurred—Topiramate—epilepsy syndrome	0.000222	0.000669	CcSEcCtD
Thiabendazole—Somnolence—Pregabalin—epilepsy syndrome	0.000221	0.000668	CcSEcCtD
Thiabendazole—Vomiting—Lamotrigine—epilepsy syndrome	0.00022	0.000665	CcSEcCtD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.00022	0.00923	CbGpPWpGaD
Thiabendazole—Rash—Lamotrigine—epilepsy syndrome	0.000218	0.000659	CcSEcCtD
Thiabendazole—Dermatitis—Lamotrigine—epilepsy syndrome	0.000218	0.000659	CcSEcCtD
Thiabendazole—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000217	0.000657	CcSEcCtD
Thiabendazole—Anorexia—Gabapentin—epilepsy syndrome	0.000217	0.000657	CcSEcCtD
Thiabendazole—Headache—Lamotrigine—epilepsy syndrome	0.000217	0.000655	CcSEcCtD
Thiabendazole—Decreased appetite—Pregabalin—epilepsy syndrome	0.000216	0.000653	CcSEcCtD
Thiabendazole—Fatigue—Pregabalin—epilepsy syndrome	0.000214	0.000648	CcSEcCtD
Thiabendazole—Hypotension—Gabapentin—epilepsy syndrome	0.000213	0.000644	CcSEcCtD
Thiabendazole—Nausea—Carbamazepine—epilepsy syndrome	0.000213	0.000643	CcSEcCtD
Thiabendazole—CYP1A1—Oxidative Stress—HMOX1—epilepsy syndrome	0.000211	0.00885	CbGpPWpGaD
Thiabendazole—Leukopenia—Topiramate—epilepsy syndrome	0.00021	0.000636	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.00021	0.00881	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—CAT—epilepsy syndrome	0.000208	0.00873	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.000207	0.00869	CbGpPWpGaD
Thiabendazole—Nausea—Lamotrigine—epilepsy syndrome	0.000206	0.000621	CcSEcCtD
Thiabendazole—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000205	0.000619	CcSEcCtD
Thiabendazole—Convulsion—Topiramate—epilepsy syndrome	0.000204	0.000615	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000203	0.000614	CcSEcCtD
Thiabendazole—Somnolence—Gabapentin—epilepsy syndrome	0.000203	0.000613	CcSEcCtD
Thiabendazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000203	0.000612	CcSEcCtD
Thiabendazole—CYP1A2—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000202	0.00848	CbGpPWpGaD
Thiabendazole—Dyspepsia—Gabapentin—epilepsy syndrome	0.000201	0.000607	CcSEcCtD
Thiabendazole—Decreased appetite—Gabapentin—epilepsy syndrome	0.000198	0.000599	CcSEcCtD
Thiabendazole—Asthenia—Valproic Acid—epilepsy syndrome	0.000197	0.000596	CcSEcCtD
Thiabendazole—Fatigue—Gabapentin—epilepsy syndrome	0.000197	0.000594	CcSEcCtD
Thiabendazole—Abdominal pain—Pregabalin—epilepsy syndrome	0.000197	0.000594	CcSEcCtD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—JUN—epilepsy syndrome	0.000195	0.00818	CbGpPWpGaD
Thiabendazole—Pruritus—Valproic Acid—epilepsy syndrome	0.000195	0.000588	CcSEcCtD
Thiabendazole—Confusional state—Topiramate—epilepsy syndrome	0.000193	0.000584	CcSEcCtD
Thiabendazole—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000188	0.000569	CcSEcCtD
Thiabendazole—CYP1A1—Oxidative Stress—GPX1—epilepsy syndrome	0.000188	0.00789	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000188	0.000568	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000186	0.000563	CcSEcCtD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	0.000186	0.00779	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000183	0.000554	CcSEcCtD
Thiabendazole—Anorexia—Topiramate—epilepsy syndrome	0.000183	0.000553	CcSEcCtD
Thiabendazole—Dizziness—Valproic Acid—epilepsy syndrome	0.000182	0.00055	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000181	0.00761	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000181	0.00758	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.00018	0.00757	CbGpPWpGaD
Thiabendazole—Abdominal pain—Gabapentin—epilepsy syndrome	0.00018	0.000545	CcSEcCtD
Thiabendazole—Hypotension—Topiramate—epilepsy syndrome	0.000179	0.000542	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000179	0.00751	CbGpPWpGaD
Thiabendazole—Asthenia—Pregabalin—epilepsy syndrome	0.000178	0.000539	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000178	0.00747	CbGpPWpGaD
Thiabendazole—Pruritus—Pregabalin—epilepsy syndrome	0.000176	0.000532	CcSEcCtD
Thiabendazole—Vomiting—Valproic Acid—epilepsy syndrome	0.000175	0.000528	CcSEcCtD
Thiabendazole—Rash—Valproic Acid—epilepsy syndrome	0.000173	0.000524	CcSEcCtD
Thiabendazole—Dermatitis—Valproic Acid—epilepsy syndrome	0.000173	0.000524	CcSEcCtD
Thiabendazole—Headache—Valproic Acid—epilepsy syndrome	0.000172	0.000521	CcSEcCtD
Thiabendazole—Somnolence—Topiramate—epilepsy syndrome	0.000171	0.000515	CcSEcCtD
Thiabendazole—Diarrhoea—Pregabalin—epilepsy syndrome	0.00017	0.000514	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.000169	0.00711	CbGpPWpGaD
Thiabendazole—Dyspepsia—Topiramate—epilepsy syndrome	0.000169	0.00051	CcSEcCtD
Thiabendazole—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000168	0.000508	CcSEcCtD
Thiabendazole—Decreased appetite—Topiramate—epilepsy syndrome	0.000167	0.000504	CcSEcCtD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—APOE—epilepsy syndrome	0.000166	0.00697	CbGpPWpGaD
Thiabendazole—Fatigue—Topiramate—epilepsy syndrome	0.000165	0.0005	CcSEcCtD
Thiabendazole—Dizziness—Pregabalin—epilepsy syndrome	0.000164	0.000497	CcSEcCtD
Thiabendazole—Asthenia—Gabapentin—epilepsy syndrome	0.000164	0.000494	CcSEcCtD
Thiabendazole—Nausea—Valproic Acid—epilepsy syndrome	0.000163	0.000494	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000163	0.00683	CbGpPWpGaD
Thiabendazole—Pruritus—Gabapentin—epilepsy syndrome	0.000161	0.000487	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000161	0.00674	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—TXNRD1—epilepsy syndrome	0.00016	0.00672	CbGpPWpGaD
Thiabendazole—Vomiting—Pregabalin—epilepsy syndrome	0.000158	0.000478	CcSEcCtD
Thiabendazole—Feeling abnormal—Topiramate—epilepsy syndrome	0.000158	0.000478	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000157	0.000474	CcSEcCtD
Thiabendazole—Rash—Pregabalin—epilepsy syndrome	0.000157	0.000474	CcSEcCtD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—TXNRD1—epilepsy syndrome	0.000157	0.00658	CbGpPWpGaD
Thiabendazole—Dermatitis—Pregabalin—epilepsy syndrome	0.000157	0.000473	CcSEcCtD
Thiabendazole—Diarrhoea—Gabapentin—epilepsy syndrome	0.000156	0.000471	CcSEcCtD
Thiabendazole—Headache—Pregabalin—epilepsy syndrome	0.000156	0.000471	CcSEcCtD
Thiabendazole—Abdominal pain—Topiramate—epilepsy syndrome	0.000152	0.000458	CcSEcCtD
Thiabendazole—Dizziness—Gabapentin—epilepsy syndrome	0.000151	0.000456	CcSEcCtD
Thiabendazole—CYP1A2—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000149	0.00625	CbGpPWpGaD
Thiabendazole—Nausea—Pregabalin—epilepsy syndrome	0.000148	0.000446	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—CAT—epilepsy syndrome	0.000148	0.0062	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000147	0.00617	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000146	0.00613	CbGpPWpGaD
Thiabendazole—Vomiting—Gabapentin—epilepsy syndrome	0.000145	0.000438	CcSEcCtD
Thiabendazole—Rash—Gabapentin—epilepsy syndrome	0.000144	0.000434	CcSEcCtD
Thiabendazole—Dermatitis—Gabapentin—epilepsy syndrome	0.000144	0.000434	CcSEcCtD
Thiabendazole—Headache—Gabapentin—epilepsy syndrome	0.000143	0.000432	CcSEcCtD
Thiabendazole—Hypersensitivity—Topiramate—epilepsy syndrome	0.000141	0.000427	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.00014	0.00589	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—FOS—epilepsy syndrome	0.000139	0.00583	CbGpPWpGaD
Thiabendazole—Asthenia—Topiramate—epilepsy syndrome	0.000138	0.000416	CcSEcCtD
Thiabendazole—Pruritus—Topiramate—epilepsy syndrome	0.000136	0.00041	CcSEcCtD
Thiabendazole—Nausea—Gabapentin—epilepsy syndrome	0.000135	0.000409	CcSEcCtD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.000134	0.00562	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.000132	0.00554	CbGpPWpGaD
Thiabendazole—Diarrhoea—Topiramate—epilepsy syndrome	0.000131	0.000397	CcSEcCtD
Thiabendazole—Dizziness—Topiramate—epilepsy syndrome	0.000127	0.000383	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—GPX1—epilepsy syndrome	0.000125	0.00524	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—JUN—epilepsy syndrome	0.000124	0.00521	CbGpPWpGaD
Thiabendazole—Vomiting—Topiramate—epilepsy syndrome	0.000122	0.000369	CcSEcCtD
Thiabendazole—Rash—Topiramate—epilepsy syndrome	0.000121	0.000366	CcSEcCtD
Thiabendazole—Dermatitis—Topiramate—epilepsy syndrome	0.000121	0.000365	CcSEcCtD
Thiabendazole—Headache—Topiramate—epilepsy syndrome	0.00012	0.000363	CcSEcCtD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000117	0.0049	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000116	0.00489	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000116	0.00485	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000115	0.00484	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000115	0.00482	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000114	0.00479	CbGpPWpGaD
Thiabendazole—Nausea—Topiramate—epilepsy syndrome	0.000114	0.000344	CcSEcCtD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000113	0.00476	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—TXNRD1—epilepsy syndrome	0.000108	0.00453	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—APOE—epilepsy syndrome	0.000106	0.00444	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000104	0.00435	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000102	0.0043	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	9.42e-05	0.00395	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	9.38e-05	0.00394	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	9.32e-05	0.00391	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	9.09e-05	0.00382	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	9.09e-05	0.00382	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	8.95e-05	0.00375	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	8.41e-05	0.00353	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	8.09e-05	0.0034	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.97e-05	0.00335	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	7.97e-05	0.00334	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	7.87e-05	0.0033	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2C19—epilepsy syndrome	7.81e-05	0.00328	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP11A1—epilepsy syndrome	7.76e-05	0.00326	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	7.71e-05	0.00323	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	7.66e-05	0.00321	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	7.36e-05	0.00309	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	7.32e-05	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	7.09e-05	0.00298	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2D6—epilepsy syndrome	7.01e-05	0.00294	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.91e-05	0.0029	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	6.89e-05	0.00289	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	6.46e-05	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	6.36e-05	0.00267	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	6.36e-05	0.00267	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	6.3e-05	0.00265	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	6.2e-05	0.0026	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	6.07e-05	0.00255	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—AGT—epilepsy syndrome	5.83e-05	0.00245	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	5.8e-05	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	5.8e-05	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—epilepsy syndrome	5.71e-05	0.0024	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	5.51e-05	0.00231	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA13—epilepsy syndrome	5.34e-05	0.00224	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	5.31e-05	0.00223	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	5.31e-05	0.00223	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	5.16e-05	0.00217	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.08e-05	0.00213	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	5.02e-05	0.0021	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	4.98e-05	0.00209	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	4.95e-05	0.00208	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.91e-05	0.00206	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.88e-05	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	4.69e-05	0.00197	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	4.67e-05	0.00196	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	4.52e-05	0.0019	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	4.47e-05	0.00188	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.41e-05	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.39e-05	0.00184	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.3e-05	0.00181	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.12e-05	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	4.06e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.06e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CERS1—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PDXK—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GLUD1—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADK—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—L2HGDH—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FAR1—epilepsy syndrome	4.05e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.02e-05	0.00169	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	3.95e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—epilepsy syndrome	3.93e-05	0.00165	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.87e-05	0.00162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EPM2A—epilepsy syndrome	3.7e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NHLRC1—epilepsy syndrome	3.7e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GAMT—epilepsy syndrome	3.7e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PNPO—epilepsy syndrome	3.7e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.51e-05	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—QDPR—epilepsy syndrome	3.44e-05	0.00145	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA4—epilepsy syndrome	3.44e-05	0.00145	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—POMC—epilepsy syndrome	3.43e-05	0.00144	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA13—epilepsy syndrome	3.41e-05	0.00143	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	3.39e-05	0.00142	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	3.39e-05	0.00142	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COX3—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLCO1A2—epilepsy syndrome	3.07e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CACNA2D2—epilepsy syndrome	3.07e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—KCNB1—epilepsy syndrome	3.07e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PFKL—epilepsy syndrome	3.07e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC6A8—epilepsy syndrome	3.07e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3e-05	0.00126	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.98e-05	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ATIC—epilepsy syndrome	2.81e-05	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UPB1—epilepsy syndrome	2.81e-05	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NEU1—epilepsy syndrome	2.81e-05	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.74e-05	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	2.7e-05	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	2.61e-05	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GBE1—epilepsy syndrome	2.61e-05	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PDXK—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CERS1—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADK—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FAR1—epilepsy syndrome	2.58e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.55e-05	0.00107	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	2.45e-05	0.00103	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	2.39e-05	0.001	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GAMT—epilepsy syndrome	2.36e-05	0.000991	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PNPO—epilepsy syndrome	2.36e-05	0.000991	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	2.36e-05	0.000991	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	2.36e-05	0.000991	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NT5E—epilepsy syndrome	2.33e-05	0.000976	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALAD—epilepsy syndrome	2.33e-05	0.000976	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	2.22e-05	0.000931	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	2.22e-05	0.000931	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—QDPR—epilepsy syndrome	2.2e-05	0.000922	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA4—epilepsy syndrome	2.2e-05	0.000922	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	2.19e-05	0.000919	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	2.17e-05	0.000911	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADSL—epilepsy syndrome	2.13e-05	0.000893	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GLUL—epilepsy syndrome	2.09e-05	0.000876	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COX3—epilepsy syndrome	2.06e-05	0.000866	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	2.05e-05	0.000859	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.96e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.96e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.96e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.96e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.96e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	1.92e-05	0.000804	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.91e-05	0.000803	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.9e-05	0.000798	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AQP1—epilepsy syndrome	1.86e-05	0.00078	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.79e-05	0.000751	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.79e-05	0.000751	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.79e-05	0.000751	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.79e-05	0.00075	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.72e-05	0.000723	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	1.68e-05	0.000706	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	1.68e-05	0.000706	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.66e-05	0.000698	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.66e-05	0.000698	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.63e-05	0.000683	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.57e-05	0.000657	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.56e-05	0.000657	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.53e-05	0.000644	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.52e-05	0.000639	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.48e-05	0.000622	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.48e-05	0.000622	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.42e-05	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.42e-05	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.38e-05	0.000581	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	1.37e-05	0.000575	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.36e-05	0.000569	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	1.34e-05	0.000561	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.33e-05	0.000558	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	1.33e-05	0.000557	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.32e-05	0.000553	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.31e-05	0.000548	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	0.000513	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.2e-05	0.000504	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	1.2e-05	0.000503	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.19e-05	0.000498	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	1.14e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.14e-05	0.000478	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	1.14e-05	0.000477	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.08e-05	0.000455	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	0.00045	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	0.00045	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.07e-05	0.00045	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TH—epilepsy syndrome	1.07e-05	0.000448	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.05e-05	0.000441	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.99e-06	0.000419	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.79e-06	0.000411	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	8.91e-06	0.000374	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	8.8e-06	0.000369	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	8.74e-06	0.000367	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	8.56e-06	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	8.52e-06	0.000358	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	8.47e-06	0.000355	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.41e-06	0.000353	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	7.95e-06	0.000334	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.66e-06	0.000322	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	7.64e-06	0.000321	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.27e-06	0.000305	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.24e-06	0.000304	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	6.98e-06	0.000293	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	6.91e-06	0.00029	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	6.84e-06	0.000287	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	6.83e-06	0.000287	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TH—epilepsy syndrome	6.81e-06	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.7e-06	0.000281	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	5.87e-06	0.000246	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.68e-06	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.61e-06	0.000235	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.46e-06	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	5.35e-06	0.000225	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.07e-06	0.000213	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	4.68e-06	0.000197	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.45e-06	0.000187	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.36e-06	0.000183	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.74e-06	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.41e-06	0.000143	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.99e-06	0.000125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	2.35e-06	9.88e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.5e-06	6.3e-05	CbGpPWpGaD
